- Home
- MGNI vs HTFL Comparison
MGNI vs HTFL Comparison
Compare MGNI & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGNI
- HTFL
- Stock Information
- Founded
- MGNI 2007
- HTFL 2007
- Country
- MGNI United States
- HTFL United States
- Employees
- MGNI N/A
- HTFL N/A
- Industry
- MGNI Computer Software: Programming Data Processing
- HTFL
- Sector
- MGNI Technology
- HTFL
- Exchange
- MGNI Nasdaq
- HTFL Nasdaq
- Market Cap
- MGNI 3.1B
- HTFL 2.8B
- IPO Year
- MGNI N/A
- HTFL 2025
- Fundamental
- Price
- MGNI $18.64
- HTFL $37.52
- Analyst Decision
- MGNI Strong Buy
- HTFL Strong Buy
- Analyst Count
- MGNI 11
- HTFL 4
- Target Price
- MGNI $26.18
- HTFL $37.00
- AVG Volume (30 Days)
- MGNI 2.4M
- HTFL 319.9K
- Earning Date
- MGNI 11-05-2025
- HTFL 11-12-2025
- Dividend Yield
- MGNI N/A
- HTFL N/A
- EPS Growth
- MGNI N/A
- HTFL N/A
- EPS
- MGNI 0.29
- HTFL N/A
- Revenue
- MGNI $685,074,000.00
- HTFL $148,540,000.00
- Revenue This Year
- MGNI $2.82
- HTFL $34.51
- Revenue Next Year
- MGNI $11.65
- HTFL $24.58
- P/E Ratio
- MGNI $65.39
- HTFL N/A
- Revenue Growth
- MGNI 5.52
- HTFL 44.32
- 52 Week Low
- MGNI $8.22
- HTFL $26.56
- 52 Week High
- MGNI $26.65
- HTFL $41.22
- Technical
- Relative Strength Index (RSI)
- MGNI 40.36
- HTFL N/A
- Support Level
- MGNI $18.45
- HTFL N/A
- Resistance Level
- MGNI $20.35
- HTFL N/A
- Average True Range (ATR)
- MGNI 0.85
- HTFL 0.00
- MACD
- MGNI 0.26
- HTFL 0.00
- Stochastic Oscillator
- MGNI 52.63
- HTFL 0.00
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.